(Q36024915)

English

Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

A R H van Zanten

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

M Oudijk

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

M K E Nohlmans-Paulssen

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Y G van der Meer

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

A R J Girbes

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

K H Polderman

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

21 July 2006

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

63

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

100-109

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Can better prescribing turn the tide of resistance?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Elements of design: the knowledge on which we build

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Importance of nondrug costs of intravenous antibiotic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Antimicrobial resistance among gram-negative organisms in the intensive care unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Antimicrobial resistance among gram-positive organisms in the intensive care unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Bacterial resistance--the clinical challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Treatment of drug-resistant pneumococcal pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Antibiotic exposure as a risk factor for emergence of resistance: the influence of concentration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Control of multiply resistant cocci: do international comparisons help?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Implementation of strategies to control antimicrobial resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Hospital mortality in relation to staff workload: a 4-year study in an adult intensive-care unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Cefotaxime. An update of its pharmacology and therapeutic use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Comparative study of pharmacokinetics and serum bactericidal activity of ceftizoxime and cefotaxime

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000713

2 October 2017

Optimizing ceftazidime pharmacodynamics in patients with acute exacerbation of severe chronic bronchitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02730.X

21 January 2018

Patient volume, staffing, and workload in relation to risk-adjusted outcomes in a random stratified sample of UK neonatal intensive care units: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02730.X

21 January 2018

Population pharmacokinetics of continuous infusion ceftazidime

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02730.X

21 January 2018

Continuous infusion ceftazidime in intensive care: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02730.X

21 January 2018

Continuous infusion of beta-lactam antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16869814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of the quality of nursing on the duration of weaning from mechanical ventilation in patients with chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16869814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacodynamics of beta-lactams

1 reference

https://pubmed.ncbi.nlm.nih.gov/16869814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.2006.02730.X

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36024915&oldid=2143958001"